Overview
- A two-month-old from Yardley was admitted to the Children’s Hospital of Philadelphia intensive care unit on June 1, received the BabyBIG antitoxin, returned home on June 6 and is now in weekly physical therapy for motor delays.
- Nara Organics issued a voluntary nationwide recall of its powdered whole‑milk infant formula on June 13 after the FDA and CDC reported three infant botulism cases in Pennsylvania, California and Washington.
- State and federal public-health labs are testing retained and returned cans from the recalled lots and so far no samples have tested positive for Clostridium botulinum, though testing remains ongoing.
- Erica and Micky Goldfin sued Nara and Target in federal court on June 22, alleging the company failed to test directly for the botulism spore, made misleading safety claims and sold formula that sickened their child.
- The cluster follows a larger ByHeart-linked powdered whole‑milk outbreak that sickened dozens and highlights that powdered formula is not sterile because C. botulinum spores can survive drying, which could prompt tighter oversight and industry changes.